146 related articles for article (PubMed ID: 27815476)
1. Prognostic Impact of a Nutritional Index Including Muscle Volume in Stage 4 Colorectal Cancer.
Nagata T; Nakase Y; Nakamura K; Sougawa A; Mochiduki S; Kitai S; Inaba S
In Vivo; 2016 11-12; 30(6):885-891. PubMed ID: 27815476
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
[TBL] [Abstract][Full Text] [Related]
3. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.
Ebadi M; Wang CW; Lai JC; Dasarathy S; Kappus MR; Dunn MA; Carey EJ; Montano-Loza AJ;
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1053-1062. PubMed ID: 30269421
[TBL] [Abstract][Full Text] [Related]
4. Impact of Preoperative Skeletal Muscle Mass and Nutritional Status on Short-and Long-Term Outcomes After Esophagectomy for Esophageal Cancer: A Retrospective Observational Study : Impact of Psoas Muscle Mass and Body Mass on Esophagectomy.
Shichinohe T; Uemura S; Hirano S; Hosokawa M
Ann Surg Oncol; 2019 May; 26(5):1301-1310. PubMed ID: 30725311
[TBL] [Abstract][Full Text] [Related]
5. Change in PMI During Neoadjuvant Therapy Is a Predictive Prognostic Marker in Rectal Cancer.
Fukuoka T; Maeda K; Nagahara H; Shibutani M; Iseki Y; Matsutani S; Hirakawa K; Ohira M
Anticancer Res; 2019 Sep; 39(9):5157-5163. PubMed ID: 31519628
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal adenocarcinoma: a retrospective cohort study.
Kuwabara S; Takeuchi Y; Sato O; Mizota T; Ichinokawa M; Murakawa K; Aoki Y; Ishido K; Ono K; Hirano S
BMC Surg; 2024 Apr; 24(1):116. PubMed ID: 38643112
[TBL] [Abstract][Full Text] [Related]
7. The relationship between computed tomography derived skeletal muscle index, psoas muscle index and clinical outcomes in patients with operable colorectal cancer.
Abbass T; Tsz Ho YT; Horgan PG; Dolan RD; McMillan DC
Clin Nutr ESPEN; 2020 Oct; 39():104-113. PubMed ID: 32859302
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection.
Tokunaga R; Sakamoto Y; Nakagawa S; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
Dis Colon Rectum; 2015 Nov; 58(11):1048-57. PubMed ID: 26445177
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia as a Predictor of Survival Among Patients With Organ Metastatic Cervical Cancer.
Yoshikawa N; Shirakawa A; Yoshida K; Tamauchi S; Suzuki S; Kikkawa F; Kajiyama H
Nutr Clin Pract; 2020 Dec; 35(6):1041-1046. PubMed ID: 32253779
[TBL] [Abstract][Full Text] [Related]
10. A lower psoas muscle volume was associated with a higher rate of recurrence in male clear cell renal cell carcinoma.
Noguchi G; Kawahara T; Kobayashi K; Tsutsumi S; Ohtake S; Osaka K; Umemoto S; Nakaigawa N; Uemura H; Kishida T; Yao M
PLoS One; 2020; 15(1):e0226581. PubMed ID: 31895931
[TBL] [Abstract][Full Text] [Related]
11. [Effects of Preoperative Skeletal Muscle Mass on the Prognosis of StageⅡ and Ⅲ Colorectal Cancer].
Nakata Y; Furuya S; Takiguchi K; Ashizawa N; Shimizu H; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Sudo M; Kawaida H; Inoue S; Kono H; Ichikawa D
Gan To Kagaku Ryoho; 2019 Oct; 46(10):1671-1674. PubMed ID: 31631171
[TBL] [Abstract][Full Text] [Related]
12. Low psoas muscle index is a poor prognostic factor for lower gastrointestinal perforation: a single-center retrospective cohort study.
Kayano H; Nomura E; Abe R; Ueda Y; Machida T; Fujita C; Uchiyama S; Endo K; Murakami K; Mukai M; Makuuchi H
BMC Surg; 2019 Nov; 19(1):181. PubMed ID: 31779610
[TBL] [Abstract][Full Text] [Related]
13. Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies.
Okumura S; Kaido T; Hamaguchi Y; Fujimoto Y; Kobayashi A; Iida T; Yagi S; Taura K; Hatano E; Uemoto S
Surgery; 2016 Mar; 159(3):821-33. PubMed ID: 26603849
[TBL] [Abstract][Full Text] [Related]
14. Psoas Muscle Index Defined by Computer Tomography Predicts the Presence of Postoperative Complications in Colorectal Cancer Surgery.
Benedek Z; Todor-Boér S; Kocsis L; Bauer O; Suciu N; Coroș MF
Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34064607
[No Abstract] [Full Text] [Related]
15. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
[TBL] [Abstract][Full Text] [Related]
16. [Impact of Muscle Mass Reduction on Postoperative Adjuvant Chemotherapy and Long-Term Prognosis in Patients with Gastric Cancer].
Nagata T; Fukuda K; Tamai M; Taniguchi A; Kamiya H; Kanbe K; Kamada Y; Iwata J; Yamaoka N; Tsukamoto K
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1915-1918. PubMed ID: 30692396
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
Miyake M; Morizawa Y; Hori S; Marugami N; Shimada K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Fujimoto K
BMC Cancer; 2017 Mar; 17(1):237. PubMed ID: 28359307
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Psoas Muscle Mass Index in Patients With Non‒ST-Segment‒Elevation Myocardial Infarction: A Prospective Observational Study.
Matsumoto H; Matsumura K; Yamamoto Y; Fujii K; Tsujimoto S; Otagaki M; Morishita S; Hashimoto K; Shibutani H; Sugiura T; Shiojima I
J Am Heart Assoc; 2020 Oct; 9(19):e017315. PubMed ID: 32975168
[TBL] [Abstract][Full Text] [Related]
19. Effect of pretreatment psoas muscle mass on survival for patients with unresectable pancreatic cancer undergoing systemic chemotherapy.
Ishii N; Iwata Y; Nishikawa H; Enomoto H; Aizawa N; Ishii A; Miyamoto Y; Yuri Y; Hasegawa K; Nakano C; Nishimura T; Yoh K; Sakai Y; Ikeda N; Takashima T; Takata R; Iijima H; Nishiguchi S
Oncol Lett; 2017 Nov; 14(5):6059-6065. PubMed ID: 29113246
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for surgery-related muscle quantity and muscle quality loss and their impact on outcome.
van Wijk L; van Duinhoven S; Liem MSL; Bouman DE; Viddeleer AR; Klaase JM
Eur J Med Res; 2021 Apr; 26(1):36. PubMed ID: 33892809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
